The FTC's Criticism of “Junk” Orange Book Filings

The FTC's Criticism of “Junk” Orange Book Filings - Ropes & Gray LLP

The FTC's Criticism of “Junk” Orange Book Filings: The Latest Squall in a Regulatory Rainstorm ... The 300 additional patents relate to 20 ...

In Law360, Attorneys Examine FTC's Criticism of “Junk” Orange ...

In Law360, Attorneys Examine FTC's Criticism of “Junk” Orange Book Filings ... In a Law360 article, attorneys examined the Federal Trade ...

FTC Expands Patent Listing Challenges, Targeting More Than 300 ...

Khan. “By challenging junk patent filings, the FTC is fighting these illegal tactics and making sure that Americans can get timely access to ...

FTC disputes new slate of Orange Book patents for weight loss ...

FTC touts continued effort to target so-called “bogus” and “junk” Orange Book patent listings ... The new warning letters are the latest salvo in ...

The FTC's Challenge to the Listing of Device Patents in the Orange ...

... Orange Book, although that decision has now been stayed pending Federal Circuit review. ... junk-listings-diabetes-weight-loss-asthma · [4] 21 CFR ...

FTC's Targeting of Orange Book Patents Won't Impede Hatch ...

In a press release, the FTC referred to them as “junk patent listings.” The challenged listings pertain to patents on devices or device ...

The FTC Strikes Out: Drug Manufacturers Refuse to Play Ball and ...

... Orange Book Patents in Response to FTC Warning Letters. What ... junk” patents as improperly listed in the Orange Book. The FTC again ...

FTC launches investigation into Teva's inhaler patents: report

While other drugmakers have relented in the face of the U.S. FTC's assault on “junk” patents in the FDA's Orange Book, Teva has stood its ...

FTC Warns Pharma Companies It Means Business with Its Orange ...

FTC Warns Pharma Companies It Means Business with Its Orange Book Listing Policy ... "By challenging junk patent filings, the FTC is fighting ...

What are 'junk' drug patents? The FTC is challenging them - Quartz

The U.S. Federal Trade Commission (FTC) announced last week that it is, for the second time, disputing hundreds of “junk” patents listed in ...

FTC issues 'junk patent' warnings to drug makers

... Orange Book, … ... “By challenging junk patent filings, the FTC is fighting these ...

FTC challenges patents held by drugmakers, including for Ozempic

The Federal Trade Commission on Tuesday said it is challenging hundreds of alleged “junk” patents held by pharmaceutical companies for 20 brand-name drugs.

Expansion to FTC's Orange Book Campaign Leads to Calls for More ...

Calling these listings “junk patent filings,” the FTC insists that these pharmaceutical companies are engaging in illegal tactics to force ...

FTC Targets 'Junk' Patents Including Novo's Ozempic, GSK's Trelegy ...

... Orange Book—are improper or inaccurate. “By filing bogus patent ... “By challenging junk patent filings, the FTC is fighting these ...

What To Watch As The FTC Targets Drug Patent Listings

... junk patents" it said were improperly listed, mostly covering drug ... Generic-drug makers have also filed suits targeting Orange Book patent ...

Food, Drug & Device - The FTC's Challenge to the Listing of Device ...

Of course, since the FTC ... Orange Book, although that decision has now been stayed pending Federal Circuit review. ... junk-listings-diabetes-weight-loss-asthma.

FTC Warns 'Junk Patents' Could Make Drugs Like Ozempic Pricier ...

The Federal Trade Commission is challenging hundreds of alleged “junk” patent listings filed by several pharmaceutical companies.

Orange Book Warnings Highlight FTC's Drug Price Focus - Law360

The Federal Trade Commission continues its brigade against so-called junk Orange Book listings. Over the past nine months, the agency has filed amicus briefs.

FTC targets 'junk patents' on Ozempic, other top drugs

FTC targets 'junk patents' on Ozempic, other top drugs. The move ... The Orange Book is a critical tool for drugmakers because they can ...

Matt Rizzolo on LinkedIn: The FTC's Criticism of “Junk” Orange Book ...

There are warning letters galore, and the first test case is likely on the horizon. The FTC's Criticism of “Junk” Orange Book Filings: The Latest Squall in ...